Home LiteratureArticle Details
PMID: 18156491 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.

Blood ·Vol. 111 ·No. 6 ·2008-03-15 ·Pages 3145-54

Marango J, Shimoyama M, Nishio H, Meyer JA, Min DJ, Sirulnik A, Martinez-Martinez Y, Chesi M, Bergsagel PL, Zhou MM, Waxman S, Leibovitch BA, Walsh MJ, Licht JD

Abstract

MMSET, identified by its fusion to the IgH locus in t(4;14)-associated multiple myeloma, possesses domains found within chromatin regulators, including the SET domain. MMSET protein is overexpressed and highly associated with chromatin in myeloma cell lines carrying t(4;14). MMSET possesses methyltransferase activity for core histone H3 lysine 4 and histone 4 lysine 20, whereas MMSET made in cells only modified H4. Segments of MMSET fused to the Gal4 DNA binding domain repressed transcription of a chromatin-embedded Gal4 reporter gene. MMSET-mediated repression was associated with increased H4K20 methylation gene and loss of histone acetylation. Consistent with this repressive activity, MMSET could form a complex with HDAC1 and HDAC2, mSin3a, and the histone demethylase LSD1, suggesting that it is a component of corepressor complexes. Furthermore, MMSET coexpression enhances HDAC1- and HDAC2-mediated repression in transcriptional reporter assays. Finally, shRNA-mediated knockdown of MMSET compromised viability of a myeloma cell line, suggesting a biologic role for the protein in malignant cell growth. Collectively, these data suggest that, by acting directly as a modifier of chromatin as well as through binding of other chromatin-modifying enzymes, MMSET influences gene expression and potentially acts as a pathogenic agent in multiple myeloma.

MeSH Terms
Animals Catalysis Cell Line Cell Nucleus/enzymology Cell Survival Chromosomes, Human, Pair 4/genetics Gene Expression Regulation Histone-Lysine N-Methyltransferase/chemistry,genetics,metabolism Histones/metabolism Humans Isoenzymes/genetics,metabolism Melanoma/enzymology,genetics Mice Models, Molecular Protein Binding Protein Structure, Tertiary Rabbits Repressor Proteins/chemistry,genetics,metabolism Transcription, Genetic/genetics
Chemicals
Histones Isoenzymes Repressor Proteins Histone-Lysine N-Methyltransferase NSD2 protein, human
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Marango Jotin
Division of Hematology/Oncology, Mount Sinai School of Medicine, New York, NY, USA.
Shimoyama Manabu
Nishio Hitomi
Meyer Julia A
Min Dong-Joon
Sirulnik Andres
Martinez-Martinez Yolanda
Chesi Marta
Bergsagel P Leif
Zhou Ming-Ming
Waxman Samuel
Leibovitch Boris A
Walsh Martin J
Licht Jonathan D
References (45)
45 references, click to expand
  1. The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation?
    FEBS Lett. 2000 May 4;473(1):1-5 PMID: 10802047
  2. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
    Blood. 2008 Jan 15;111(2):856-64 PMID: 17942756
  3. Regulation of chromatin structure by site-specific histone H3 methyltransferases.
    Nature. 2000 Aug 10;406(6796):593-9 PMID: 10949293
  4. A unique mRNA initiated within a middle intron of WHSC1/MMSET encodes a DNA binding protein that suppresses human IL-5 transcription.
    Am J Respir Cell Mol Biol. 2001 Jan;24(1):90-98 PMID: 11152655
  5. Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells.
    Mol Cell Biol. 2001 Jun;21(11):3820-9 PMID: 11340173
  6. NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines.
    Genomics. 2001 May 15;74(1):79-88 PMID: 11374904
  7. Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3.
    J Biol Chem. 2001 Jul 6;276(27):25309-17 PMID: 11316813
  8. Translating the histone code.
    Science. 2001 Aug 10;293(5532):1074-80 PMID: 11498575
  9. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase.
    Mol Cell. 2001 Dec;8(6):1207-17 PMID: 11779497
  10. Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy.
    Blood. 2002 Sep 1;100(5):1579-83 PMID: 12176874
  11. Active genes are tri-methylated at K4 of histone H3.
    Nature. 2002 Sep 26;419(6905):407-11 PMID: 12353038
  12. The polycomb group protein EZH2 is involved in progression of prostate cancer.
    Nature. 2002 Oct 10;419(6907):624-9 PMID: 12374981
  13. MLL targets SET domain methyltransferase activity to Hox gene promoters.
    Mol Cell. 2002 Nov;10(5):1107-17 PMID: 12453418
  14. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.
    Blood. 2003 Feb 15;101(4):1520-9 PMID: 12393535
  15. Structure and catalytic mechanism of the human histone methyltransferase SET7/9.
    Nature. 2003 Feb 6;421(6923):652-6 PMID: 12540855
  16. A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript.
    Blood. 2003 Mar 15;101(6):2374-6 PMID: 12433679
  17. NSD1 is essential for early post-implantation development and has a catalytically active SET domain.
    EMBO J. 2003 Jun 16;22(12):3153-63 PMID: 12805229
  18. Tools for comparative protein structure modeling and analysis.
    Nucleic Acids Res. 2003 Jul 1;31(13):3375-80 PMID: 12824331
  19. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression.
    Mol Cell Biol. 2003 Dec;23(24):9375-88 PMID: 14645547
  20. The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant.
    Br J Haematol. 2004 Apr;125(1):64-8 PMID: 15015970
  21. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin.
    Genes Dev. 2004 Jun 1;18(11):1251-62 PMID: 15145825
  22. Chromatin targeting of de novo DNA methyltransferases by the PWWP domain.
    J Biol Chem. 2004 Jun 11;279(24):25447-54 PMID: 14998998
  23. CCAAT displacement protein/cut homolog recruits G9a histone lysine methyltransferase to repress transcription.
    Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11257-62 PMID: 15269344
  24. A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.
    Clin Cancer Res. 2004 Sep 1;10(17):5692-701 PMID: 15355895
  25. A vector for expressing GAL4(1-147) fusions in mammalian cells.
    Nucleic Acids Res. 1989 Sep 25;17(18):7539 PMID: 2798115
  26. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.
    Nucleic Acids Res. 1991 May 11;19(9):2499 PMID: 2041787
  27. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13931-6 PMID: 8943038
  28. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression.
    Nature. 1997 May 1;387(6628):49-55 PMID: 9139821
  29. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma.
    Hum Mol Genet. 1998 Jul;7(7):1071-82 PMID: 9618163
  30. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
    Blood. 1998 Nov 1;92(9):3025-34 PMID: 9787135
  31. Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1.
    J Biol Chem. 2004 Dec 24;279(52):54348-57 PMID: 15471871
  32. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.
    Cell. 2004 Dec 29;119(7):941-53 PMID: 15620353
  33. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer.
    Nat Genet. 2005 Apr;37(4):391-400 PMID: 15765097
  34. Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.
    Blood. 2005 May 15;105(10):4060-9 PMID: 15677557
  35. The theoretical basis of transcriptional therapy of cancer: can it be put into practice?
    J Clin Oncol. 2005 Jun 10;23(17):3957-70 PMID: 15867201
  36. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.
    Oncogene. 2005 Aug 25;24(36):5543-51 PMID: 15897876
  37. Regulation of LSD1 histone demethylase activity by its associated factors.
    Mol Cell. 2005 Sep 16;19(6):857-64 PMID: 16140033
  38. Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myeloma.
    Br J Haematol. 2005 Oct;131(2):214-8 PMID: 16197452
  39. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.
    Nature. 2006 Jul 6;442(7098):86-90 PMID: 16728976
  40. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2.
    Nature. 2006 Jul 6;442(7098):100-3 PMID: 16728977
  41. Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.
    Genes Chromosomes Cancer. 2007 Mar;46(3):226-38 PMID: 17171682
  42. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
    Nat Cell Biol. 2007 Jul;9(7):804-12 PMID: 17589499
  43. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
    Cancer Cell. 2007 Aug;12(2):115-30 PMID: 17692804
  44. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
    Cancer Cell. 2007 Aug;12(2):131-44 PMID: 17692805
  45. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.
    Mol Cell. 2000 May;5(5):811-20 PMID: 10882117
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
2008-03-15
Epub
2007-00-21
Pages
3145-54
Language
English
Region
United States
NLM ID
7603509
PMCID
PMC2265454
Subset
IM
Grants
NCI NIH HHS · P50 CA100707 · United States
NCI NIH HHS · P50 CA100707-060008 · United States
NIA NIH HHS · R01 AG020686 · United States
NIA NIH HHS · R01 AG020686-05 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]